$IBTA

Leach Bryan sold $771K of IBTA

Leach Bryan (CEO AND PRESIDENT) sold 21,895 shares of Ibotta, Inc. (IBTA) at an average of $35.21 ($34.63–$35.79, $0.77M total) across 4 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leach Bryan
Published Jul 6, 2026, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
high confidence
Mentioned
$IBTA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The newest information is the disclosed sale size, dates, and weighted-average prices; it may influence short-term sentiment but does not, by itself, change fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the pre-arranged nature and lack of other catalysts keep the signal modest.

03

What to watch

The article provides only the sale details; it does not state whether there were concurrent purchases, changes in guidance, or other catalysts that would contextualize the selling.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-06 after sales dated 2026-07-01 to 2026-07-02.

Background

This is an SEC Form 4 insider transaction: CEO/president Leach Bryan sold IBTA shares in multiple trades under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$IBTANeutralHigh confidence
Context

Ibotta CEO Leach Bryan sold about $770.8K of IBTA shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived around insider-selling headlines.

Evidence & confidence

The filing is a disclosed open-market sale by the CEO under a pre-arranged 10b5-1 plan, with no accompanying operational/regulatory/financial catalyst in the text.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still be read by some traders as confidence erosion, especially if paired with other negative signals (not present here).

Key entities

  • Ibotta, Inc.

    Public company subject of the Form 4 insider sale disclosure (IBTA).

  • Leach Bryan

    CEO and President; reported open-market sales under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBTAMedAI 8/10

Ibotta (IBTA) Q2 2026 Earnings Call Transcript

Ibotta (IBTA) reported Q2 2026 revenue of $88.9 million, up 3% year over year, and adjusted EBITDA of $16.5 million. Third-party redemption revenue rose 27% to $61.5 million as the company shifted users to its publisher network. Q3 revenue guidance is $86 million to $90 million. Ibotta also said it added 11,500 7-Eleven locations via a partnership.

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million Redemption revenue grew by 10% year-over-year to $80